Investing Profile

Timothy Haines

InvestorVC
Managing Partner: Abingworth became part of Carlyle (NASDAQ: CG) on 1 August 2022. at Abingworth
Photo of Timothy Haines, Managing Partner at Abingworth

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
5858 CONNECTIONS
MiOrden.com Network
918 CONNECTIONS
various Network
462 CONNECTIONS
Fs Medical Supplies Network
372 CONNECTIONS
INSEAD Network
250 CONNECTIONS
cb
Abingworth Managing Partner
$15.0M - $30.0M
$22.5M
3
$465M

Sign in to see all 3 investments on record.

Sign in with Google →
CEO Fs Medical SuppliesPresent
CEO MiOrden.comPresent
CEO variousPresent
General Manager Baxter International Inc.Present
General Manager / VP R and D and Manufacturing Telectronics Pacing Systems, Inc.Present
Panel Member - Health Innovation Challenge Fund Wellcome TrustPresent
Advisory Board Member Oxford University InnovationPresent
Non Executive Chair IMU BiosciencesPresent
Chair TenUPresent
CEO HotmailPresent
CEO Intervascular Inc. and Patient Monitoring Maquet Getinge GroupPresent
CEO Astex Pharmaceuticals, Inc. (US)Present
Partner AbingworthPresent
Managing Partner AbingworthPresent
Chairman and Managing Partner AbingworthPresent
Managing Partner: Abingworth became part of Carlyle (NASDAQ: CG) on 1 August 2022. AbingworthPresent
Managing Director and Executive Partner AbingworthPresent
INSEAD Master of Business Administration (MBA) Business Administration and Management, General
Sign in with Google →
Sign in with Google →